Table 1 ICD-related genes.
Gene | Description | Role | References |
|---|---|---|---|
PDIA3 | Promotes the uptake of dead cell-associated antigens | Active | |
HMGB1 | Promotes the synthesis of pro-inflammatory factors including type I IFNs | Active | |
AGER | PRR of HMGB1 | Active | |
TLR2 | PRR of HMGB1 | Active | |
TLR4 | PRR of HMGB1 | Active | |
MYD88 | Part of TLR4 signaling systems | Active | |
LY96 | Part of TLR5 signaling systems | Active | |
HSPA1A | Stimulates the uptake of dead cell-associated antigens | Active | |
HSP90AA1 | Stimulates the uptake of dead cell-associated antigens | Active | |
ANXA1 | Guides the final approach of APCs to dying cells | Active | |
FPR1 | PRR of ANXA1 | Active | |
P2RX7 | Purinergic receptor | Active | |
P2RY2 | Purinergic receptor | ACTIVE | |
NT5E | The ATP-degrading ectoenzyme | Inhibition | |
ENTPD1 | The ATP-degrading ectoenzyme | Inhibition | |
EIF2S1 | eIF2αphosphorylation correlates with CALR exposure and tumor infiltration by DCs and CTLs | Active | |
EIF2AK3 | eIF2αphosphorylase | Active | |
CALR | Promotes the uptake of dead cell-associated antigens | Active | |
LRP1 | PRR of CALR | Active | |
CD47 | As anti-phagocytic signals that antagonize CALR | Inhibition | |
CASP8 | ICD-associated exposure of CALR | Active | |
ERN1 | ICD-associated exposure of CALR | Active | |
XBP1 | ICD-associated exposure of CALR | Active | |
BCAP31 | ICD-associated exposure of CALR | Active | |
BAX | ICD-associated exposure of CALR | Active | |
BAK1 | ICD-associated exposure of CALR | Active | |
VAMP1 | ICD-associated exposure of CALR | Active | |
SNAP25 | ICD-associated exposure of CALR | Active | |
STC1 | retaining CALR intracellularly | Inhibition | |
TLR3 | PRR of RNA | Active | |
ATG5 | Autophagy | Active | |
ATG7 | Autophagy | Active | |
CXCL10 | Stimulates T-cell recruitment | Active | |
CXCR3 | CXCL10 receptor | Active | |
NLRP3 | Mediate pro-inflammatory effects | Active | |
CASP1 | Mediate pro-inflammatory effects | Active | |
IL1B | Mediate pro-inflammatory effects | Active | |
Il17a | Mediate pro-inflammatory effects | Active | |
Il17ra | Il17a receptor | Active | |
PIK3CA | Ablation compromised Chemotherapy-induced ICD and Hyp-PDT induced ICD | Active | |
IL6 | High IL6 associated with enhanced ICD | Active | |
TNF | High TNF associated with enhanced ICD | Active | |
IL1R1 | Ablation compromised ICD | Active | |
PRF1 | Ablation compromised ICD | Active | |
FOXP3 | Mediate immunosuppressive effects | Inhibition | |
CTLA4 | Mediate immunosuppressive effects | Inhibition | |
IL10 | Mediate immunosuppressive effects | Inhibition | |
CD4 | Depletion of these cells compromised ICD | Active | |
CD8A | Depletion of these cells compromised ICD | Active | |
CD8B | Depletion of these cells compromised ICD | Active | |
CGAS | Generating type I interferons | Active | |
STING1 | generating type I interferons | Active | |
IFNAR1 | Type I IFNs receptor | Active | |
IFNAR2 | Type I IFNs receptor | Active | |
Type I IFNs | Immunostimulatory | Active | |
IFNA1 | Active | ||
IFNA2 | Active | ||
IFNA4 | Active | ||
IFNA5 | Active | ||
IFNA6 | Active | ||
IFNA7 | Active | ||
IFNA8 | Active | ||
IFNA10 | Active | ||
IFNA13 | Active | ||
IFNA14 | Active | ||
IFNA16 | Active | ||
IFNA17 | Active | ||
IFNA21 | Active | ||
IFNB1 | Active | ||
IFNG | Active |